Skip to main content
SpringerLink
Log in

Pathology of Esophageal Squamous Cell Carcinoma

  • Chapter
  • First Online:
Esophageal Squamous Cell Carcinoma

Abstract

Superficial esophageal cancers are classified into three major types including type 0-I (superficial and protruding type including type 0-Ip (pedunculated) and type 0-Is (sessile)), type 0-II (superficial and flat type including type 0-IIa (slightly elevated), type 0-IIb (flat) and type 0-IIc (slightly depressed)), and type 0-III (superficial and excavated type). More protruded (type 0-I) or more depressed (type 0-III) lesions are associated with deeper invasion in the submucosa. All submucosal cancers have a substantial risk of lymph node metastases. Consequently, intraepithelial carcinoma or carcinoma invading the lamina propria is generally treated by endoscopic resection. Advanced esophageal cancers are classified into four types including type 1 (protruding type), type 2 (ulcerative and localized type), type 3 (ulcerative and infiltrative type), and type 4 (diffusely infiltrative type). The two most frequent types are types 2 and 3. Iodine staining method is useful not only for optimal visualization of esophageal squamous mucosal abnormalities but also for detecting groups at high risk of multicentric cancer in the upper aerodigestive tract. Clinicopathologic prognostic factors include TNM stage, lymph node metastasis, tumor invasion depth, lympho-vascular invasion, intramural metastasis, tumor vascularity, infiltrating growth pattern, inflammatory response, tumor budding, tumor nest configuration, pathologic response to neoadjuvant therapy, completeness of surgical resection, and the patient’s general health condition. The subtypes of esophageal squamous cell carcinoma include basaloid squamous carcinoma, carcinosarcoma, adenosquamous carcinoma, verrucous carcinoma, and lymphoepithelioma-like carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Japan Esophageal Society (2008) Japanese classification of esophageal cancer, second English version. Kanehara, Tokyo

    Google Scholar 

  2. Japan Esophageal Society (2009) Japanese classification of esophageal cancer, tenth edition: part 1. Esophagus 6:1–25

    Article  Google Scholar 

  3. Japan Esophageal Society (2009) Japanese classification of esophageal cancer, tenth edition: part II and III. Esophagus 6:71–94

    Article  Google Scholar 

  4. Bosman F, Carneiro F, Hruban R et al (eds) (2010) WHO classification of tumours of the digestive system, the fourth edition, 4th edn. IARC, Lyon

    Google Scholar 

  5. Edge SB, Byrd DR, Compton CC et al (eds) (2010) AJCC cancer staging manual, 7th edn. Springer, New York

    Google Scholar 

  6. Sobin LH, Gospodarowicz MK, Wittekind C (eds) (2009) TNM classification of malignant tumours, 7th edn. Wiley-Blackwell, Oxford

    Google Scholar 

  7. Dawsey SM, Fleischer DE, Wang GQ et al (1998) Mucosal iodine staining improves endoscopic visualization of squamous dysplasia and squamous cell carcinoma of the esophagus in Linxian, China. Cancer 83:220–231

    Article  PubMed  CAS  Google Scholar 

  8. Nakanishi Y, Ochiai A, Yoshimura K et al (1998) The clinicopathologic significance of small areas unstained by Lugol’s iodine in the mucosa surrounding resected esophageal carcinoma: an analysis of 147 cases. Cancer 82:1454–1459

    Article  PubMed  CAS  Google Scholar 

  9. Nakanishi Y, Ochiai A, Shimoda T et al (1997) Epidermization in the esophageal mucosa: unusual epithelial changes clearly detected by Lugol’s staining. Am J Surg Pathol 21:605–609

    Article  PubMed  CAS  Google Scholar 

  10. Mori M, Adachi Y, Matsushima T et al (1993) Lugol staining pattern and histology of esophageal lesions. Am J Gastroenterol 88:701–705

    PubMed  CAS  Google Scholar 

  11. Park JY, Kim DM, Min BH et al (2012) Esophageal parakeratosis mimicking endoscopic appearance of superficial esophageal neoplastic lesion such as dysplasia. Dig Endosc 24:117–119

    Article  PubMed  Google Scholar 

  12. Yoshikawa I, Yamasaki M, Yamasaki T et al (2005) Lugol chromoendoscopy as a diagnostic tool in so-called endoscopy-negative GERD. Gastrointest Endosc 62:698–703

    Article  PubMed  Google Scholar 

  13. Boyce HW (2003) Barrett esophagus. Endoscopic findings and what to biopsy. J Clin Gastroenterol 36(Suppl 1):S6–S18

    Article  PubMed  Google Scholar 

  14. Ozawa S, Tachimori Y, Baba H et al (2012) Comprehensive registry of esophageal cancer in Japan, 2004. Esophagus 9:75–98

    Article  Google Scholar 

  15. Raza MA, Mazzara PF (2011) Sarcomatoid carcinoma of esophagus. Arch Pathol Lab Med 135:945–948

    PubMed  Google Scholar 

  16. Ide H, Ozawa S, Matsubara H et al (2009) Comprehensive registry of esophageal cancer in Japan, 2000. Esophagus 6:27–47

    Article  Google Scholar 

  17. Participants in the Paris Workshop (2003) The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon. Gastrointest Endosc 58(Suppl 6):S3–S43

    Article  Google Scholar 

  18. Kodama M, Kakegawa T (1998) Treatment of superficial cancer of the esophagus: a summary of responses to a questionnaire on superficial cancer of the esophagus in Japan. Surgery 123:432–439

    Article  PubMed  CAS  Google Scholar 

  19. Takubo K (2008) Pathology of the esophagus, 2nd edn. Springer, Tokyo

    Google Scholar 

  20. Muto H, Hironaka S, Nakane M et al (2002) Association of multiple Lugol-voiding lesions with synchronous and metachronous esophageal squamous-cell carcinoma in patients with head and neck cancer. Gastrointest Endosc 56:517–521

    Article  PubMed  Google Scholar 

  21. Katada C, Muto M, Tanabe S et al (2013) Surveillance after endoscopic mucosal resection or endoscopic submucosal dissection for esophageal squamous cell carcinoma. Dig Endosc 25(Suppl 1):39–43

    Article  PubMed  Google Scholar 

  22. Cui R, Kamatani Y, Takahashi A et al (2009) Functional variants in ADH1B and ALDH2 coupled with alcohol and smoking synergistically enhance esophageal cancer risk. Gastroenterology 137:1768–1775

    Article  PubMed  CAS  Google Scholar 

  23. Hirota WK, Zuckerman MJ, Adler DG et al (2006) ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc 63(4):570–580

    Article  PubMed  Google Scholar 

  24. Islami F, Boffetta P, Ren JS et al (2009) High-temperature beverages and foods and esophageal cancer risk – a systemic review. Int J Cancer 125:491–524

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  25. Morton LM, Gilbert ES, Hall P et al (2012) Risk of treatment-related esophageal cancer among breast cancer survivors. Ann Oncol 23:3081–3091

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  26. Anderson SR, Sinacori JT (2007) Plummer–Vinson syndrome heralded by postcricoid carcinoma. Am J Otolaryngol 28:22–24

    Article  PubMed  Google Scholar 

  27. Palladino-Davis AG, Mendez BM, Fisichella PM et al (2013) Dietary habits and esophageal cancer. Dis Esophagus (Epub ahead of print)

    Google Scholar 

  28. Landgren AM, Landgren O, Gridley G et al (2011) Autoimmune disease and subsequent risk of developing alimentary tract cancers among 4.5 million U.S. male Veterans. Cancer 117:1163–1171

    Article  PubMed  PubMed Central  Google Scholar 

  29. Chandan VS, Murray JA, Abraham SC (2008) Esophageal lichen planus. Arch Pathol Lab Med 132:1026–1029

    PubMed  Google Scholar 

  30. Lack E, Worsham F, Callihan M et al (1980) Granular cell tumor: a clinicopathologic study of 110 patients. J Surg Oncol 13:301–306

    Article  PubMed  CAS  Google Scholar 

  31. Abraham S, Singh V, Yardley J et al (2001) Hyperplastic polyps of the esophagus and esophagogastric junction. Am J Surg Pathol 25:1180–1187

    Article  PubMed  CAS  Google Scholar 

  32. Weinberg JA (1972) Lymphatics of the esophagus. In: Haagensen CD, Feind CR, Herter FP, Slanetz CA Jr, Weinberg JA (eds) The lymphatics in cancer. Saunders, Philadelphia

    Google Scholar 

  33. Rice TW, Zuccaro G, Adelstein DJ et al (1998) Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status. Ann Thorac Surg 65:787–792

    Article  PubMed  CAS  Google Scholar 

  34. Tajima T, Nakanishi Y, Tachimori Y et al (2000) Significance of involvement by squamous cell carcinoma of the ducts of esophageal submucosal glands. Cancer 89:248–254

    Article  PubMed  CAS  Google Scholar 

  35. Nishimaki T, Tanaka O, Suzuki T et al (1993) Tumor spread in superficial esophageal cancer: histopathologic basis for rational surgical treatment. World J Surg 17:766–772

    Article  PubMed  CAS  Google Scholar 

  36. Chu P, Stagias J, West AB et al (1997) Diffuse pagetoid squamous cell carcinoma in situ of the esophagus. Cancer 79:1865–1870

    Article  PubMed  CAS  Google Scholar 

  37. Ishihara A, Mori T, Koono M (2002) Diffuse pagetoid squamous cell carcinoma of the esophagus combined with choriocarcinoma and mucoepidermoid carcinoma: an autopsy case report. Path Int 53:147–152

    Article  Google Scholar 

  38. Eguchi T, Nakanishi Y, Shimoda T et al (2006) Histopathological criteria for additional treatment after endoscopic mucosal resection for esophageal cancer: analysis of 464 surgically resected cases. Mod Pathol 19:475–480

    Article  PubMed  Google Scholar 

  39. Tajima Y, Nakanishi Y, Ochiai A et al (2000) Histopathologic findings predicting lymph node metastasis and prognosis of patients with superficial esophageal carcinoma: analysis of 240 surgically resected tumors. Cancer 88:1285–1293

    Article  PubMed  CAS  Google Scholar 

  40. Kato H, Tachimori Y, Watanabe H et al (1992) Intramural metastasis of thoracic esophageal carcinoma. Int J Cancer 50:49–52

    Article  PubMed  CAS  Google Scholar 

  41. Kuwano H, Nakajima M, Miyazaki T et al (2003) Distinctive clinicopathological characteristics in esophageal squamous cell carcinoma. Ann Thorac Cardiovasc Surg 9:6–13

    PubMed  Google Scholar 

  42. Igaki H, Kato H, Tachimori Y et al (2003) Prognostic evaluation of patients with clinical T1 and T2 squamous cell carcinomas of the thoracic esophagus after 3-field lymph node dissection. Surgery 133:368–374

    Article  PubMed  Google Scholar 

  43. Ide H, Nakamura T, Hayashi K et al (1994) Esophageal squamous cell carcinoma: pathology and prognosis. World J Surg 18:321–330

    Article  PubMed  CAS  Google Scholar 

  44. Tanigawa N, Matsumura M, Amaya H et al (1997) Tumor vascularity correlates with the prognosis of patients with esophageal squamous cell carcinoma. Cancer 79:220–225

    Article  PubMed  CAS  Google Scholar 

  45. Sarbia M, Bittinger F, Porschen R et al (1995) Prognostic value of histopathologic parameters of esophageal squamous cell carcinoma. Cancer 76:922–927

    Article  PubMed  CAS  Google Scholar 

  46. Schumacher K, Haensch W, Roefzaad C et al (2001) Prognostic significance of activated CD8+ T cell infiltration within esophageal carcinomas. Cancer Res 61:3932–3936

    PubMed  CAS  Google Scholar 

  47. Miyata H, Yoshioka A, Yamasaki M et al (2009) Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy. Cancer 115:3324–3334

    Article  PubMed  Google Scholar 

  48. Nakanishi Y, Ochiai A, Kato H et al (2001) Clinicopathological significance of tumor nest configuration in patients with esophageal squamous cell carcinoma. Cancer 91:1114–11120

    Article  PubMed  CAS  Google Scholar 

  49. Tanabe T, Kanda T, Kosugi S et al (2007) Extranodal spreading of esophageal squamous cell carcinoma: Clinicopathological characteristics and prognostic impact. World J Surg 31:2192–2198

    Article  PubMed  Google Scholar 

  50. Sung CO, Park CK, Kim SH et al (2011) Classification of epithelial-mesenchymal transition phenotypes in esophageal squamous cell carcinoma is strongly associated with patient prognosis. Mod Pathol 24:1060–1068

    Article  PubMed  Google Scholar 

  51. Yamamoto M, Doki Y, Shiozaki H et al (2000) Evaluation of the histologic effect of chemoradiation therapy for squamous cell carcinomas of the esophagus by assessing morphologic features of surgical specimens. Dis Esophagus 13:293–300

    Article  PubMed  CAS  Google Scholar 

  52. Takagawa R, Kunisaki C, Makino H et al (2009) Efficacy of chemoradiotherapy with low-dose cisplatin and continuous infusion of 5-fluorouracil for unresectable squamous cell carcinoma of the esophagus. Dis Esophagus 22:482–489

    Article  PubMed  Google Scholar 

  53. Shimada H, Okazumi S, Shiratori T et al (2009) Impact of lymph node involvement in T2 or T3 thoracic esophageal squamous cell carcinoma. Hepatogastroenterology 56:1039–1043

    PubMed  Google Scholar 

  54. Akutsu Y, Matsubara H (2011) The significance of lymph node status as s prognostic factor for esophageal cancer. Surg Today 41:1190–1195

    Article  PubMed  Google Scholar 

  55. Tachimori T, Nagai Y, Kanamori N et al (2011) Pattern of lymph node metastases of esophageal squamous cell carcinoma based on the anatomical lymphatic drainage system. Dis Esophagus 24:33–38

    Article  PubMed  CAS  Google Scholar 

  56. Rizk N, Venkatraman E, Park B et al (2006) The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American Joint Committee on Cancer staging system. J Thorac Cardiovasc Surg 132:1374–1381

    Article  PubMed  Google Scholar 

  57. Peyre CG, Hagen JA, DeMeester SR et al (2008) Predicting systemic disease in patients with esophageal cancer after esophagectomy: a multinational study on the significance of the number of involved lymph nodes. Ann Surg 248:979–985

    Article  PubMed  Google Scholar 

  58. Lin DC, Du XL, Wang MR (2009) Protein alterations in esophageal squamous cell carcinoma and clinical implications: a review. Dis Esophagus 22:9–20

    Article  PubMed  Google Scholar 

  59. Chen J, Kwong DL, Cao Q et al (2013) Esophageal squamous cell carcinoma: advance in genomics and molecular genetics. Dis Esophagus. doi:10.1111/dote.12088

    Google Scholar 

  60. Costa NM, Lima SC, Simao TD et al (2013) The potential molecular markers to improve interventions through the natural history of esophageal squamous cell carcinoma. Biosci Rep. doi:10.1042/BSR20130063

  61. Taylor PR, Abnet CC, Dawsey SM (2013) Squamous dysplasia – the precursor lesion for esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 22:540–552

    Article  PubMed  PubMed Central  Google Scholar 

  62. Schlemper RJ, Dawsey SM, Itabashi M et al (2000) Differences in diagnostic criteria for esophageal squamous cell carcinoma between Japanese and Western pathologists. Cancer 88:996–1006

    Article  PubMed  CAS  Google Scholar 

  63. Wang WC, Wu TT, Chandan VS et al (2011) Ki-67 and ProEXC are useful immunohistochemical markers in esophageal squamous intraepithelial neoplasia. Hum Pathol 42:1430–1437

    Article  PubMed  CAS  Google Scholar 

  64. Kobayashi Y, Nakanishi Y, Taniguchi H et al (2009) Histological diversity in basaloid squamous cell carcinoma of the esophagus. Dis Esophagus 22:231–238

    Article  PubMed  CAS  Google Scholar 

  65. Imamhasan A, Mitomi H, Saito T et al (2012) Immunohistochemical and oncogenetic analyses of the esophageal basaloid squamous cell carcinoma in comparison with conventional squamous cell carcinomas. Hum Pathol 43:2012–2023

    Article  PubMed  CAS  Google Scholar 

  66. Sarbia M, Verreet P, Bittinger F et al (1997) Basaloid squamous cell carcinoma of the esophagus: diagnosis and prognosis. Cancer 79:1871–1878

    Article  PubMed  CAS  Google Scholar 

  67. Hishida T, Nakanishi Y, Shimoda T et al (2002) Esophageal basaloid carcinoma with marked myoepithelial differentiation. Pathol Int 52:313–317

    Article  PubMed  Google Scholar 

  68. Yachida S, Nakanishi Y, Shimoda T et al (2004) Adenosquamous carcinoma of the esophagus. Oncology 66:218–225

    Article  PubMed  Google Scholar 

  69. Bombi JA, Riverola A, Bordas JM et al (1991) Adenosquamous carcinoma of the esophagus: a case report. Pathol Res Pract 187:514–519

    PubMed  CAS  Google Scholar 

  70. Lam KY, Dickens P, Loke SL et al (1994) Squamous cell carcinoma of the esophagus with mucin-producing component (muco-epidermoid carcinoma and adenosquamous carcinoma): a clinicopathologic study and a review of literature. Eur J Surg Oncol 20:25–31

    PubMed  CAS  Google Scholar 

  71. Sweetser S, Jacobs NL, Song LM (2012) Endoscopic diagnosis and treatment of esophageal verrucous squamous cell cancer. Dis Esophagus. doi:10.1111/j.1442-2050.2012.01434.x

  72. Nakasono M, Hirokawa M, Suzuki M et al (2007) Lymphoepithelioma-like carcinoma of the esophagus: report of a case with non-progressive behavior. J Gastroenterol Hepatol 22:2344–2347

    Article  PubMed  Google Scholar 

  73. Sashiyama H, Nozawa A, Kimura M et al (1999) Case report: a case of lymphoepithelioma-like carcinoma of the esophagus and review of the literature. J Gastroenterol Hepatol 14:534–539

    Article  PubMed  CAS  Google Scholar 

  74. Chen PC, Pan CC, Hsu WH et al (2003) Epstein–Barr virus-associated lymphoepithelioma-like carcinoma of the esophagus. Hum Pathol 34:407–411

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology and Laboratory Medicine, Tulane University School of Medicine, 1430 Tulane Avenue, SL-79, Room 6520, New Orleans, LA, 70112, USA

    Yukihiro Nakanishi MD, PhD

Authors
  1. Yukihiro Nakanishi MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yukihiro Nakanishi MD, PhD .

Editor information

Editors and Affiliations

  1. Department of Surgery, International Goodwill Hospital, Yokohama, Kanagawa, Japan

    Nobutoshi Ando

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Japan

About this chapter

Cite this chapter

Nakanishi, Y. (2015). Pathology of Esophageal Squamous Cell Carcinoma. In: Ando, N. (eds) Esophageal Squamous Cell Carcinoma. Springer, Tokyo. https://doi.org/10.1007/978-4-431-54977-2_2

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-54977-2_2

  • Published:

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-54976-5

  • Online ISBN: 978-4-431-54977-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation